Difference in preventive effects between the phosphodiesterase IV inhibitor rolipram and anti-arthritic drugs on antigen-induced arthritis in mice

Immunological Investigations

Volumn 36, Issue 2, 2007, Pages 131-145

  Yamaki, Kouya ^a   Li, Xiaojuan ^a   Hossain, Md Aslam ^b   Alam, A H M Khurshid ^b   Taneda, Shinji ^c   Yanagisawa, Rie ^d   Takano, Hirohisa ^d   Yoshino, Shin ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF RAJSHAHI   (Bangladesh)

^c Air Pollutants Health Effects Research Team   (Japan)

^d NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

Anti arthritic drug; Antigen induced arthritis; Phosphodiesterase IV; Rolipram; Th1; Th2

Indexed keywords

ANTIGEN; AURANOFIN; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INDOMETACIN; INTERLEUKIN 10; METHOTREXATE; OVALBUMIN; PENICILLAMINE; ROLIPRAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTHRITIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DBA 1 MOUSE; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TREATMENT DURATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; AURANOFIN; DEXAMETHASONE; FEMALE; IMMUNOGLOBULIN G; INDOMETHACIN; INTERFERON TYPE II; INTERLEUKIN-10; METHOTREXATE; MICE; MICE, INBRED DBA; OVALBUMIN; PENICILLAMINE; PHOSPHODIESTERASE INHIBITORS; ROLIPRAM; TH1 CELLS; TH2 CELLS;

EID: 33847715976     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130600746008     Document Type: Article

References (37)

1. Corry, D. B., Folkesson, H. G., Warnock, M. L., Erle, D. J., Matthay, M. A. Wiener- Kronish, J. P., Locksley, R. M. (1996). Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hypersensitivity. J. Exp. Med. 183(1):109-117.
2. Dickensheets, H. L., Venkataraman, C., Schindler, U., Donnelly, R. P. (1999) Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc. Natl. Acad. Sci. USA 96(19):10800-10805.
3. Elliot, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Bijl, H., Woody, J. N. (1994). Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis. Lancet 344(8930):1125-1127.
4. Feldmann, M., Brennan, F. M., Maini R. N. (1996a). Rheumatoid arthritis. Cell 85 (3):307-310.
5. Feldmann, M., Dower, S., Brennan F. M. (1996b). The role of cytokines in normal and pathological situations. In: Brennan FM, Feldmann M, eds., Cytokines in Autoimmunity R.G. Landes Co. Austin, pp. 1-24.
6. Finkelman, F. D., Katona, I. M., Mosmann, T. R., Coffman, R. L. (1988). IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140(4):1022-1027.
7. Gantner, F., Gotz, C., Gekeler, V., Schudt, C., Wendel, A., Hatzelmann, A. (1998). Phosphodiesterase profile of human B-lymphocytes from normal and atopic donors and the effects of PDE inhibition on B-cell proliferation. Br. J. Pharmacol. 123(6):1031-1038.
8. Genain, C. P., Roberts, T., Davis, R. L., Nguyen, M. H., Uccelli, A., Faulds, D., Li, Y., Hedgpeth, J., Hauser, S. L. (1995). Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA 92(8):3601-3605.
9. Gondal, J. A., Eiseman, J. L., Alvares, A. P. (1987). Regulation of heme metabolism and monooxygenases in liver and kidney: influence of therapeutically used gold compounds. J. Pharmacol. Exp. Ther. 241(2):540-546.
10. Hannan, M. T. (1996). Epidemiologic perspectives on women with arthritis: an overview. Arthritis Care Res. 9(6):424-434.
11. Joosten, L. A., Lubberts, E., Durez, P., Helsen, M. M., Jacobs, M. J., Goldman, M., van den Berg, W. B. (1997). Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destraction. Arthritis Rheum. 40(2):249-260.
12. Kammer, G. M. (1988). The adenylate cyclase cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9(7-8):222-229.
13. Krause, M., Kuhne, G. (1988). Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences. Xenobiotica 18(5):561-571.
14. Liblau, R. S., Singer, S. M., McDevitt, H. O. (1995). Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16(1):34-38.
15. Lorence, R. M., Edwards, C. K. 3rd., Walter, R. J., Kelley, K. W., Greager, J. A. (1990). In vivo effects of recombinant interferon-γ: augumentation of endotoxin-induced necrosis of tumors and priming of macrophages for tumor necrosis factor-α production. Cancer Lett. 53(2-3):223-229.
16. McIntyre, K. W., Shuster, D. J., Gillooly, K. M., Warrier, R. R., Connaughton, S. E., Hall, L. B., Arp, L. H., Gately, M. K., Magram, J. (1996). Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur. J. Immunol. 26(12):2933-2938.
17. Mossmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., Coffman, R. L. (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136(7):2348-2357.
18. Mossmann, T. R., Coffman, R. L. (1989). TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
19. Nishikori T., Irie, K., Suganuma, T., Ozaki, M., Yoshioka, T. (2002). Anti-inflammatory potency of FR167653, a p38 mitogen-activated protein kinase inhibitor, in mouse models of acute inflammation. Eur. J. Pharmacol. 451(3):327-333.
20. Ochel, M., Vohr, H. M., Pfeiffer, C., Gleichmann, E. (1991). IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J. Immunol. 146(9):3006-3011.
21. Olivenstein, R., Taha, R., Minshall, E. M., Hamid, Q. A. (1999). IL-4 and IL-5 mRNA expression in induced sputum of asthmatic subjects: comparison with bronchial wash. J. Allergy Clin. Immunol. 103(2 Pt 1):238-245.
22. Ross, S. E., Williams, R. O., Mason, L. J., Mauri, C., Marinova-Mutafchieva, L., Malfait, A. M., Maini, R. N., Feldmann M. (1997). Suppression of TNF-α expression, inhibition of Th1 activity, and ameliolation of collagen-induced arthritis by rolipram. J. Immunol. 159(12):6253-6259.
23. Scola, M. P., Thompson, S. D., Brunner, H. I., Tsoras, M. K., Witte, D., van Dijk, M. A., Grom, A. A., Passso, M. H., Glass, D. N. (2002). Interferon-γ:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. J. Rheumatol. 29(2):369-378.
24. Sigidin, Y. A., Loukina, G. V., Skurkovich, B., Skurkovich, S. (2001). Randomized, double-blind trial of anti-interferon-γ antibodies in rheumatoid arthritis. Scand. J. Rheumatol. 30(4):203-207.
25. Snapper, C. M., Paul, W. E. (1987). Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236(4804):944-947.
26. Sommer, N., Loschmann, P. A., Northoff, G. H., Weller, M., Steinbrecher, A., Steinbach, J. P., Lichtenfels, R., Meyermann, R., Riethmuller, A., Fontana, A. (1995). The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat. Med. 1(3):244-248.
27. Toivonen, M.-L., Linden, I.-B., Gripenberg, M., Vapaatalo, H. (1984). The usability of the MRL/l mouse strain in detection of anti-rheumatic drugs. Agents Actions 15(5/6):578-583.
28. van Roon, J. A., van Roy, J. L., Duits, A., Lafeber, F. P., Bijilsma, J. W. (1995). Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann. Rheum. Dis. 54(10):836-840.
29. Woodruff, T. M., Strachan, A. J., Dryburgh, N., Shiels, I. A., Reid, R. C., Fairlie, D. P., Taylar, S. M. (2002). Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monoarticular arthritis in the rat. Arthritis Rheum. 46(9):2476-2485.
30. Yamaki, K., Li, X., Uchida, H., Alam, A. H. M. K., Hossain, Md. A., Yanagisawa, R., Takano, H., Taneda, S., Hayashi, H., Mori, Y., Yoshino, S. (2004). Effects of the phosphodiesterase IV inhibitor rolipram on Th1 and Th2 immune responses in mice. J. Pharm. Pharmacol. 56(7):877-882.
31. Yamaki, K., Uchida, H., Harada, Y., Li, X., Yanagisawa, R., Takano, H., Hayashi, H., Taneda, S., Mori, Y., Yoshino, S. (2003a). Effect of methotrexate on Th1 and Th2 immune responses in mice. J. Pharm. Pharmacol. 55(12):1661-1666.
32. Yamaki, K., Uchida, H., Harada, Y., Yanagisawa, R., Takano, H., Hayashi, H., Mori, Y., Yoshino, S. (2003b). Effect of the nonsteroidal anti-inflammatory drugs indomethacin on Th1 and Th2 immune responses in mice. J. Pharm. Sci. 92(8):1723-1729.
33. Yin, Z., Braun, J., Neure, L., Wu, P., Liu, L., Eggens, U., Sieper, J. (1997). Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum. 40(10):1788-1797.
34. Yocum, D. E. (1999). T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis. Semin. Arthritis Rheum. 29(1):27-35.
35. Yoshino, S. (1995). Antigen-induced arthritis in rats is suppressed by the inducing antigen administered orally before, but not after immunization. Cell. Immunol. 163(1):55-58.
36. Yoshino, S., Murata, Y., Ohsawa, M. (1998). Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4. J. Immunol. 161(12):6904-6908.
37. Yoshino, S., Sasatomi, E., Mori, Y., Sagai, M. (1999). Oral administration of lipopolysaccharide exacerbates collagen-induced arthritis in mice. J. Immunol. 163(6):3417-3422.